Trademark: 90517922
Word
ASPIRIN THERAPY VAZALORE
Status
Registered
Status Code
700
Status Date
Tuesday, March 29, 2022
Serial Number
90517922
Registration Number
6688135
Registration Date
Tuesday, March 29, 2022
Mark Type
3000
Filing Date
Monday, February 8, 2021
Published for Opposition
Tuesday, October 12, 2021

Trademark Owner History

Classifications
5 Aspirin
The mark consists of the stylized wording "ASPIRIN THERAPY" next to a heart design overlaid with an electrocardiograph line, all above the stylized wording "VAZALORE".
"ASPIRIN THERAPY"

Trademark Events
Sep 20, 2023
Automatic Update Of Assignment Of Ownership
Apr 20, 2022
Teas Change Of Correspondence Received
Apr 20, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 29, 2022
Registered-Principal Register
Feb 23, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 22, 2022
Allowed Principal Register - Sou Accepted
Feb 15, 2022
Statement Of Use Processing Complete
Jan 26, 2022
Use Amendment Filed
Feb 11, 2022
Case Assigned To Intent To Use Paralegal
Jan 26, 2022
Teas Statement Of Use Received
Jan 4, 2022
Teas Post Publication Amendment Received
Dec 7, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 12, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2021
Published For Opposition
Sep 22, 2021
Notification Of Notice Of Publication E-Mailed
Sep 2, 2021
Approved For Pub - Principal Register
Sep 2, 2021
Examiner's Amendment Entered
Sep 2, 2021
Notification Of Examiners Amendment E-Mailed
Sep 2, 2021
Examiners Amendment E-Mailed
Sep 2, 2021
Examiners Amendment -Written
Sep 1, 2021
Assigned To Examiner
May 13, 2021
Notice Of Design Search Code E-Mailed
May 12, 2021
New Application Office Supplied Data Entered
Feb 11, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24